111614
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
子宫内膜癌不同分子亚型的临床病理特征分析：一项单中心回顾性研究
Authors Pan R, Luo Y, Wu B, Rao H, Yang H
Received 26 June 2025
Accepted for publication 1 December 2025
Published 8 December 2025 Volume 2025:18 Pages 7381—7393
DOI https://doi.org/10.2147/IJGM.S549714
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Dana Kristjansson
Ru Pan,1,* Yu Luo,1,* Boming Wu,1 Hui Rao,2 Haikun Yang1
1Department of Gynaecology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Department of Laboratory Medicine, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Ru Pan; Haikun Yang, Department of Gynaecology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China, Email xiaoru0121@126.com; 13923023911@139.com
Background: There is significant heterogeneity in the proportion of molecular subtypes of endometrial cancer and its relationship with clinicopathological characteristics among different races and regions. It aims to analyze the differences in the clinicopathological characteristics of different molecular subtypes of endometrial cancer in Eastern Guangdong Province, China.
Methods: Five hundred and sixty-three endometrial cancer patients in Meizhou People’s Hospital from January 2018 to August 2024 were collected. The relationship of molecular subtypes (DNA polymerase epsilon (POLE) mutant, mismatch repair deficiency (dMMR), p53 abnormal, and non-specific molecular profile (NSMP)) and clinicopathological characteristics (age, reproductive history, menopausal status, and pathological data covered histological type, tumor differentiation, muscular infiltration, lymphovascular invasion, perineural invasion) were analyzed.
Results: The molecular subtypes dMMR, p53 abnormal, POLE mutant, and NSMP were detected in 197 (35.0%), 155 (27.5%), 52 (9.2%), and 159 (28.2%) patients, respectively. There were statistically significant differences in distributions of histological types (p = 0.012, χ2= 14.073), tumor differentiation (p < 0.001, χ2= 16.457), and disease stage (p = 0.019, χ2= 9.796) in NSMP and non-NSMP cases. The proportion of POLE mutant in endometrioid carcinoma was higher than those of other histological types, while the proportion of p53 abnormal was relatively high in high-grade and highly invasive histological types. The proportion of p53 abnormal subtype was relatively high among patients with mixed carcinoma. In addition, the proportions of poor tumor differentiation in the dMMR and p53 abnormal groups were higher than that in the NSMP group.
Conclusion: The distribution of molecular subtypes among patients with different histopathological types shows significant differences. The proportion of POLE mutant type in endometrioid carcinoma is higher than that of other histological types, while the proportion of p53 abnormal type is relatively high in high-grade and highly invasive histological types such as serous carcinoma and clear cell carcinoma. It provides valuable reference for guiding the diagnosis and treatment of endometrial cancer by integrating molecular subtypes with clinicopathological characteristics.
Keywords: endometrial cancer, molecular subtype, clinicopathological characteristics, POLE, NSMP
1Department of Gynaecology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Department of Laboratory Medicine, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Ru Pan; Haikun Yang, Department of Gynaecology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China, Email xiaoru0121@126.com; 13923023911@139.com
Background: There is significant heterogeneity in the proportion of molecular subtypes of endometrial cancer and its relationship with clinicopathological characteristics among different races and regions. It aims to analyze the differences in the clinicopathological characteristics of different molecular subtypes of endometrial cancer in Eastern Guangdong Province, China.
Methods: Five hundred and sixty-three endometrial cancer patients in Meizhou People’s Hospital from January 2018 to August 2024 were collected. The relationship of molecular subtypes (DNA polymerase epsilon (POLE) mutant, mismatch repair deficiency (dMMR), p53 abnormal, and non-specific molecular profile (NSMP)) and clinicopathological characteristics (age, reproductive history, menopausal status, and pathological data covered histological type, tumor differentiation, muscular infiltration, lymphovascular invasion, perineural invasion) were analyzed.
Results: The molecular subtypes dMMR, p53 abnormal, POLE mutant, and NSMP were detected in 197 (35.0%), 155 (27.5%), 52 (9.2%), and 159 (28.2%) patients, respectively. There were statistically significant differences in distributions of histological types (p = 0.012, χ2= 14.073), tumor differentiation (p < 0.001, χ2= 16.457), and disease stage (p = 0.019, χ2= 9.796) in NSMP and non-NSMP cases. The proportion of POLE mutant in endometrioid carcinoma was higher than those of other histological types, while the proportion of p53 abnormal was relatively high in high-grade and highly invasive histological types. The proportion of p53 abnormal subtype was relatively high among patients with mixed carcinoma. In addition, the proportions of poor tumor differentiation in the dMMR and p53 abnormal groups were higher than that in the NSMP group.
Conclusion: The distribution of molecular subtypes among patients with different histopathological types shows significant differences. The proportion of POLE mutant type in endometrioid carcinoma is higher than that of other histological types, while the proportion of p53 abnormal type is relatively high in high-grade and highly invasive histological types such as serous carcinoma and clear cell carcinoma. It provides valuable reference for guiding the diagnosis and treatment of endometrial cancer by integrating molecular subtypes with clinicopathological characteristics.
Keywords: endometrial cancer, molecular subtype, clinicopathological characteristics, POLE, NSMP